Daniel Palmer

4PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|Feb 25, 2026
Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service.

Jessica Hale, Timothy Gilbert, Martyn Stott

|Dec 04, 2025
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer.

Christoph Springfeld, Thilo Hackert, Daniel H Palmer

|Jun 11, 2025
Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial.

Yuk Ting Ma, Jianmin Zuo, Amanda Kirkham

Pageof 1